CCO Interactive Case Challenges

Interactive Case Challenges: Treatment Considerations for Patients with Prostate Cancer

Interactive Case Challenges

Early-Stage, Aggressive Prostate Cancer in a Non-Elderly Patient With no Comorbidities

Program Director:
Timothy Kuzel, MD

Faculty:

James A. Eastham, MD headshotBrett Carver, MD headshot
  • James A. Eastham, MD
  • Brett Carver, MD

CME CREDIT INFORMATION

Release Date: 04/25/05

Expiration Date: 04/24/06


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Test your ability to manage a patient with early-stage, aggressive prostate cancer in non-elderly patient with no co-morbid conditions.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate treatment alternatives depending on patient risk factors.

  • Discuss the multidisciplinary management of a non-elderly patient with early-stage, aggressive prostate cancer and with no comorbidities.

  • Review the role of adjuvant therapy in patients with aggressive prostate cancer.

Management of Metastatic Prostate Cancer in a Nonelderly Patient With Comorbid Medical Conditions

Program Director:
Timothy Kuzel, MD

Faculty:

Tomasz M. Beer, MD headshot
  • Tomasz M. Beer, MD

CME CREDIT INFORMATION

Release Date: 06/09/05

Expiration Date: 06/08/06


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Evaluate the first- and second-line treatment options for a younger patient with metastatic hormone refractory prostate cancer and significant comorbidities.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate treatment alternatives depending on patient risk factors.

  • Describe the role of chemotherapy as primary therapy for metastatic hormone-refractory prostate cancer.

  • Discuss appropriate management of a nonelderly patient with metastatic hormone- refractory prostate cancer.

Treatment of a Patient With Metastatic Prostate Cancer and no Other Comorbidities

Program Director:
Timothy Kuzel, MD

Faculty:

Tomasz M. Beer, MD headshot
  • Tomasz M. Beer, MD

CME CREDIT INFORMATION

Release Date: 07/21/05

Expiration Date: 07/20/06


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Manage the treatment of metastatic prostate cancer in a patient with no other comorbidities.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss appropriate management of patients with metastatic hormone-refractory prostate cancer in the absence of other comorbid medical conditions.

  • Better formulate treatment plans based on specific patient risk factors.

  • Evaluate the role of chemotherapy as primary treatment for metastatic hormone-refractory prostate cancer.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.